As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: September 12, 2013
by Barbara Bronson Gray for HealthDay:
Differences in signs, symptoms could be related to ‘beta-amyloid fibrils’ responsible for plaque, study hints.
Differences in plaque-forming structures in the brains of Alzheimer’s patients may offer clues to why the disease can progress more rapidly or be less severe in some people, a new study suggests.
The research could spur the development of new imaging agents that highlight specific structures in the brain — called beta-amyloid fibrils — improving the reliability and specificity of diagnosis, according to Robert Tycko, lead author of the paper published Sept. 12 in the journal Cell.
“Variations in disease may have a structural basis and be due to differences in the molecular structure of the fibrils,” said Tycko, a senior investigator with the intramural research program of the U.S. National Institutes of Health.
The study represents an important advance in Alzheimer’s research, an expert not involved with the study noted.
Beta-amyloid fibrils are responsible for the amyloid plaques seen in Alzheimer’s disease, the most common form of dementia. Alzheimer’s is the sixth leading cause of death in the United States and more than 5 million Americans have the disease, according to the Alzheimer’s Association.
For the research, the scientists took tissue from the brains of two deceased female Alzheimer’s patients with different signs and symptoms of the disease. They extracted beta-amyloid from the tissue and used it as “seeds” to grow beta-amyloid fibrils. The investigators found that the same “seeds” — the amino acid sequence — could assemble into different molecular structures.
Using nuclear magnetic resonance and electron microscopy to visualize the beta-amyloid fibrils in the patients’ brain tissue, the scientists discovered correlations between variations in the disease and differences in molecular structure.
“There are at least two different varieties [of amyloid structure] in Alzheimer’s disease,” Tycko said. “And certain fibril structures may be more likely than others to cause the disease.”
Tycko explained that while the research team was able to determine that there are at least two structural varieties of Alzheimer’s disease, they were unable to prove that there are correlations between variations in disease and molecular structure.
He said he hopes that the research will eventually lead to the ability to tell someone with memory loss whether or not the problem is likely to lead to a serious or fast-moving form of Alzheimer’s.
One expert not involved with the research called the discovery a “technical tour de force.”
“The research is a huge step forward,” said Terrence Town, a professor of physiology and biophysics at the Keck School of Medicine at the University of Southern California. “They have accomplished something we have been trying to do for a decade.”
For years, researchers have been focusing on something smaller than a fibril, called an oligomer, considered to be especially toxic to the brain, Town explained. “Now this paper is drawing attention to something different: fibrils.”
The findings will help researchers focus on the fibrils, ideally working toward developing ways to identify and diagnose people in the earliest stages of the disease, Town said.
For young adults with autosomal dominant Alzheimer’s disease (AD), molecular markers can identify changes associated with the disease before clinical onset, according to a study published online Feb. 12 in JAMA Neurology. Yakeel T. Quiroz, Ph.D., from Massachusetts...
Foods can determine whether someone will suffer from dementia in later years, according to researchers at the Hebrew University of Jerusalem’s Faculty of Agriculture, Food and Environment in Rehovot. A large-scale international study that...
Taking care of someone with Alzheimer’s disease and other forms of dementia is not an easy task. Caregiving is a long-term endeavour that is mentally, emotionally, physically, and financially demanding, and is a role that...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.